120 related articles for article (PubMed ID: 11107065)
1. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung.
Yamasaki M; Takeshima Y; Fujii S; Matsuura M; Tagawa K; Inai K
Pathol Int; 2000 Nov; 50(11):891-6. PubMed ID: 11107065
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
3. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung.
Yamasaki M; Takeshima Y; Fujii S; Kitaguchi S; Matsuura M; Tagawa K; Inai K
Pathol Int; 2000 Oct; 50(10):778-85. PubMed ID: 11107049
[TBL] [Abstract][Full Text] [Related]
4. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
Nishisaka T; Takeshima Y; Inai K
Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
[TBL] [Abstract][Full Text] [Related]
6. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the p53 gene of lung carcinomas with sarcomatous transformation (spindle cell carcinoma): analysis of four cases.
Kawano R; Takeshima Y; Inai K
Pathol Int; 1996 Jan; 46(1):38-45. PubMed ID: 10846548
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.
Froudarakis ME; Sourvinos G; Fournel P; Bouros D; Vergnon JM; Spandidos DA; Siafakas NM
Chest; 1998 Apr; 113(4):1091-4. PubMed ID: 9554652
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia.
Suzuki K; Ogura T; Yokose T; Nagai K; Mukai K; Kodama T; Nishiwaki Y; Esumi H
Int J Cancer; 1998 Aug; 79(4):384-9. PubMed ID: 9699531
[TBL] [Abstract][Full Text] [Related]
10. Analysis of loss of heterozygosity in small adenocarcinomas of the lung.
Yoshioka H; Takeuchi T; Matsuno Y; Yamada T; Shimosato Y; Hirohashi S; Noguchi M
Jpn J Clin Oncol; 1998 Apr; 28(4):240-4. PubMed ID: 9657008
[TBL] [Abstract][Full Text] [Related]
11. A case of double primary adenocarcinoma of the lung with multiple atypical adenomatous hyperplasia.
Anami Y; Matsuno Y; Yamada T; Takeuchi T; Nakayama H; Hirohashi S; Noguchi M
Pathol Int; 1998 Aug; 48(8):634-40. PubMed ID: 9736412
[TBL] [Abstract][Full Text] [Related]
12. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.
Kanazawa H; Ebina M; Ino-Oka N; Shimizukawa M; Takahashi T; Fujimura S; Imai T; Nukiwa T
Am J Pathol; 2000 Apr; 156(4):1289-98. PubMed ID: 10751354
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.
Takamochi K; Ogura T; Suzuki K; Kawasaki H; Kurashima Y; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Esumi H
Am J Pathol; 2001 Nov; 159(5):1941-8. PubMed ID: 11696455
[TBL] [Abstract][Full Text] [Related]
14. Association between p53 mutation and clinicopathological features of non-small cell lung cancer.
Guang SG; Ogura T; Sekine I; Yokozaki M; Esumi H; Kodama T; Nagai K
Jpn J Clin Oncol; 1997 Aug; 27(4):211-5. PubMed ID: 9379505
[TBL] [Abstract][Full Text] [Related]
15. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.
Field JK; Neville EM; Stewart MP; Swift A; Liloglou T; Risk JM; Ross H; Gosney JR; Donnelly RJ
Br J Cancer; 1996 Dec; 74(12):1968-74. PubMed ID: 8980398
[TBL] [Abstract][Full Text] [Related]
16. Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer.
Tsuchiya E; Tanigami A; Ishikawa Y; Nishida K; Hayashi M; Tokuchi Y; Hashimoto T; Okumura S; Tsuchiya S; Nakagawa K
Jpn J Cancer Res; 2000 Jun; 91(6):589-96. PubMed ID: 10874210
[TBL] [Abstract][Full Text] [Related]
17. p53 alterations in atypical alveolar hyperplasia of the human lung.
Slebos RJ; Baas IO; Clement MJ; Offerhaus GJ; Askin FB; Hruban RH; Westra WH
Hum Pathol; 1998 Aug; 29(8):801-8. PubMed ID: 9712420
[TBL] [Abstract][Full Text] [Related]
18. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
19. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
20. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ
J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
